By Andrea Golan, Genevieve Meehan
Apr 1, 2024
For years, the efficacy of cannabis lab test results has been widely discussed across the California cannabis industry due to inflated potency test results and inconsistencies in results due to labs using different methodologies for testing cannabis. This has changed with the implementation of lab testing standardization.
By David M. Ullian, Tim Callahan
Mar 7, 2024
This Insights post provides an overview of recent changes impacting Massachusetts cannabis businesses. We break down the new Model Host Community Agreement (HCA), explaining its purpose, usage, and accessibility. Additionally, we explore the updated application and renewal processes, highlighting the mandatory inclusion of compliant HCAs or waivers. This blog serves as a valuable resource for both new and existing cannabis businesses seeking to navigate the evolving regulatory landscape in Massachusetts.
Nov 2, 2023
Watch as panelists address the current lab testing and compliance issues in the industry, testing standards across the country, and the importance of reliable testing.
Sep 21, 2023
Join Casey Leaver and Stephen Pemberton at the Cannabis Quality Conference on October 18! Casey and Steve will discuss creating a culture of compliance to help your cannabis operation thrive.
By Shawn Hauser
Aug 31, 2023
The federal government formally acknowledged the medical use and low potential of abuse for cannabis, with the US Department of Health and Human Services recommending that cannabis be rescheduled to Schedule III under the Controlled Substances Act. While placement in Schedule III still criminalizes commercial cannabis activity at the federal level, it is a significant step on the path to ending prohibition. This rescheduling would eliminate the application of 280E tax penalties, reduce the level of criminal liability for cannabis-related activity, reduce barriers to research, legitimize the industry through gaining credibility and engagement by physicians and the medical community, and support a growing industry for the American economy.
By Andrea Golan
Aug 23, 2023
Minnesota's new adult-use cannabis law makes some significant changes to the state's existing rules governing the manufacture and sale of hemp-derived cannabinoid products. Read this article for information on some of the most notable changes, including seller registration requirements, prohibited products, and cannabinoid serving limits.
Aug 17, 2023
So, you received your provisional Connecticut cannabis license or just renewed your final license. Now what? It’s time to get on the path to success as an operational and compliant cannabis operator.
By Genevieve Meehan, Emily Hackman
Jul 26, 2023
As cannabis markets mature, regulatory agencies typically increase compliance enforcement through inspections and audits. It has become increasingly clear that The Oklahoma Medical Marijuana Authority has shifted toward increased and escalated enforcement and heightened license application scrutiny. Learn more about this shift and review the updated OMMA inspection forms by reading this Insights article.
Jun 28, 2023
Watch this Vicente LLP session, where cannabis training and compliance experts from Vicente, Cannabis Trainers and Rootwurks will discuss the gold standards for cannabis employee training and the most common (and costly) compliance pitfalls they’ve seen across the industry.
By Casey Leaver
Apr 10, 2023
The Massachusetts cannabis employee data breach made public last month by the Cannabis Control Commission, combined with recent announcements about the Commission’s “secret shopper” program and an increase in unannounced inspections at licensed facilities, presents a trifecta of reminders for marijuana establishments to revisit their standard operating policies and procedures (SOPs).
By Shane Pennington
Apr 4, 2023
Cannabis researchers can study the dispensary strains and products people are actually using around the country right now... without violating federal law… and without Congress lifting a finger. Read this article for two simple tricks to do so.
By Shane Pennington
Nov 9, 2022
What outcomes are possible from the impending administrative process to reconsider cannabis’s schedule I status? What are the implications of those various possible outcomes? And how should we all proceed in light of it all?
By Shane Pennington
Oct 21, 2022
To appreciate the gravity of the President’s scheduling directive and what could happen next, you need to understand (1) how the administrative process the President has set in motion will actually work and (2) how the agencies in charge have used it to affirm and reaffirm cannabis’s schedule I1 status repeatedly throughout the Comprehensive Drug Abuse Prevention and Control Act of 1970’s (“CSA”) history. Those topics are covered in this article.
By Shane Pennington
Oct 21, 2022
President Biden’s scheduling directive is enormously important. In fact, if permitted to run its course, it could revolutionize federal drug control law to a far greater degree than any of the many pending cannabis legalization bills.
